Patent Baristas

After Abbott Laboratories announced that it would not launch new medicines in Thailand in response to the military-installed government’s decision not to honor the company’s patent for its AIDS drug, the company has now announced a new plan. Abbott and World Health Organization (WHO) Director-General, Margaret Chan, have agreed on a neew approach to provide […]

The Northwestern Journal of Technology & Intellectual Property is offering up a symposium this week entitled “Of BRICs and Mortar: Technological Drivers in Booming Economies“. The so-called “BRICs” are the world’s four fastest growing economies – Brazil, Russia, India, and China. This year’s Symposium will be hosted at Northwestern University School of Law on April […]

Abbott Laboratories announced that it will not launch new medicines in Thailand in response to the military-installed government’s decision not to honor the company’s patent for an AIDS drug.  On January 29th 2007 the Thai Ministry of Public Health announced that it would issue compulsory licenses for Kaletra and for Plavix, an anti-platelet medication that […]

I received information regarding a new IP consulting firm, Criterion Dynamics, tagline: “IP Centric Market Research”. Criterion Dynamics is a consulting firm offering patent and trademark searching and customized competitive intelligence services. They specialize in secondary research and claim to know the fundamentals of business and to “understand where intellectual property fits into the bigger […]

It was three up and three down for the Wisconsin Alumni Research Foundation (WARF) as the U.S. Patent and Trademark Office (USPTO) rejected the claims of its patents on human embryonic stem cells. Embryonic stem cells, as their name suggests, are derived from embryos that develop from eggs that have been fertilized in vitro. Embryonic stem cells […]

Some recent new blogs have come across my desk that I wanted to pass along to readers.The first is the self-explanatory Generic Pharmaceuticals & IP, which looks at the IP issues in terms of the generic drug manufacturer. This blog offers the perspective of a patent attorney working in a generic pharmaceutical company in India. […]